Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CLOSE
X
HOME CAPABILITIES Why Single Cell SNV SNV + CNV DNA + Protein Applications Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Genome Integrity Assay Biomarker Development Cell and Gene Therapy Products & Services Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
RESOURCES BLOG PODCAST COMPANY About Us Careers Newsroom Events Distributors & Service Providers SUPPORT CENTER CONTACT PORTAL
X
Home Events 65th ASH Annual Meeting & Exposition
Events

65th ASH Annual Meeting & Exposition

San Diego, CA
December 9 - December 12, 2023

San Diego Convention Center

111 Harbor Dr

San Diego, CA 92101

Booth 2015

Directions
Register

Join us December 9-12 for the 65th ASH Annual Meeting & Exposition. Visit the Mission Bio team at Booth 2015 to learn more about our applications in hematology, including our newly announced Tapestri® Single-cell MRD (scMRD) AML Multiomics Assay.

SESSION
120 Clonal Targeting of DNA Damage Response Pathways Eradicates Myeloproliferative Neoplasms
DATE & TIME
12.09.2023
10:45AM PST
LOCATION
Marriott Grand Ballroom 8-9
PRESENTERS
Monika Toma, PhD
SESSION
1317 Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial
DATE & TIME
12.09.2023
5:30PM PST
LOCATION
Halls G-H
PRESENTERS
Christopher Maximilian Arends
SESSION
1575 BRAF-Mutated Acute Myeloid Leukemia (AML) Represents a Distinct, Prognostically Poor Subgroup Enriched in Myelodysplasia-Related (MR-)AML
DATE & TIME
12.09.2023
5:30PM PST
LOCATION
Halls G-H
PRESENTERS
Yazan Abu-Shihab, MD
SESSION
1606 Clonal Heterogeneity and Evolution during Treatment in High Hyperdiploid B-Cell Acute Lymphoblastic Leukemia
DATE & TIME
12.09.2023
5:30PM PST
LOCATION
Halls G-H
PRESENTERS
Margo Aertgeerts, MD
SESSION
1784 Leukemic Driver Clones Can Arise Independently and Outcompete MPN Cells in Post-MPN Secondary AML
DATE & TIME
12.09.2023
5:30PM PST
LOCATION
Halls G-H
PRESENTERS
Tyler M Parsons, PhD
SESSION
423 Venetoclax Has Potent Efficacy in NPM1 mutated AML with Acquired Resistance Associated with Either Perturbed Pro-Survival Signalling or NPM1 wild-Type Populations
DATE & TIME
12.10.2023
10:00AM PST
LOCATION
Marriott Grand Ballroom 8-9
PRESENTERS
Chong Chyn Chua, MBBS, FRACP, FRCPA, PhD
SESSION
2688 BAX Mutated Clonal Hematopoiesis Arises Following Treatment with the BCL2 Inhibitor Class of Therapeutics across a Range of Hematological and Non-Hematological Neoplasms
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Ing Soo Tiong, FRACP, FRCPA, MPhil
SESSION
2931 Single-Cell Proteogenomics Analysis of AML Samples Treated with Decitabine and Venetoclax Reveals Divergent Treatment Escape Mechanisms
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Yi June Kim
SESSION
2958 Minimal Residual Disease Detection By Single Cell DNA Sequencing Technology: A Feasible Approach for Clinical Application and Identification of the Landscape of MRD Clones
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Ana Alfonso Pierola, M.D., Ph.D.
SESSION
3003 A Multi-Omic Study Unveils a Clonal Population of TET2-Mutated Infiltrating T-Cells in Germinal Center B Cell Lymphomas (DLBCL and FL)
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Sofia Huerga
SESSION
3452 Molecular Attributes of CAR T Cell Fitness in Patients with Chronic Lymphocytic Leukemia
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Xiaoli Mi, MD
SESSION
3580 Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations
DATE & TIME
12.10.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Livius Penter, MD
SESSION
705 Branching Trajectories and Diversification of Clonal Escape in Aplastic Anemia Revealed By Single-Cell Genomics
DATE & TIME
12.11.2023
11:00AM PST
LOCATION
Room 6DE
PRESENTERS
Masanori Yoshida, MD, PhD
SESSION
747 Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells
DATE & TIME
12.11.2023
11:00AM PST
LOCATION
Ballroom 20CD
PRESENTERS
Joachim R. Goethert, MD
SESSION
996 Divergent Functions of ERK2 Substrate Binding Modalities in Myeloproliferative Neoplasm
DATE & TIME
12.10.2023
5:45PM PST
LOCATION
Pacific Ballroom Salons 21-22
PRESENTERS
Billy Truong
SESSION
4116 Multiomic Characterization of Myelodysplastic Neoplasms (MDS) with Micromegakaryocytes Highlights the Role of EZH2-RUNX1 deregulation in Disease Physiopathology and Response to Targeted Therapies
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Miranda Fernandez-Serrano, MSc
SESSION
4135 First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Ilaria Crespiatico
SESSION
4301 Clonal Medicine Targeting DNA Damage Response Eradicates AML
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Monika Toma, PhD
SESSION
4257 Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Ioannis Mantzaris
SESSION
4334 Multiomic Single-Cell Sequencing May Distinguish BCR-ABL-Mutated Acute Myeloid Leukemia (AML) from Blast Crisis Chronic Myelogenous Leukemia (BC-CML)
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Vanessa E. Kennedy, MD
SESSION
4714 Single Cell Multi-Omic Correlation of Single Nucleotide Variants, Copy Number Variation and Surface Epitopes for Clonal Profiling of Myeloma
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Adam Sciambi, PhD
SESSION
5014 Single-Cell Genomics and Proteomics Reveals Venetoclax-Resistant Monocytic Differentiation of TP53 LOH Clones in TP53 Mutant AML
DATE & TIME
12.11.2023
6:00PM PST
LOCATION
Halls G-H
PRESENTERS
Edward Ayoub, PhD

SIGN UP FOR PRODUCT AND EVENT UPDATES
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CAPABILITIES
Why Single Cell SNV SNV + CNV DNA + Protein
APPLICATIONS
Oncology Research Multiple Myeloma AML MRD Precision Medicine Genome Editing Biomarker Development Cell and Gene Therapy
PRODUCTS & SERVICES
Tapestri Platform Panels Pharma Assay Development PAD for Cell & Gene Therapy PAD for Drug Development
COMPANY CAREERS NEWSROOM EVENTS BLOG RESOURCES SUPPORT CENTER CONTACT Terms of Use Privacy Policy Terms and Conditions of Sale Client Data Security & Retention
REQUEST QUOTE